Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
Frontotemporal lobar degeneration
Genetic tauopathies
Neuronal degeneration
Tau pathology
Journal
Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
11
06
2022
accepted:
26
08
2022
revised:
18
08
2022
pubmed:
7
9
2022
medline:
9
11
2022
entrez:
6
9
2022
Statut:
ppublish
Résumé
Frontotemporal lobar degeneration with MAPT pathogenic variants (FTLD-MAPT) has heterogeneous tau pathological inclusions postmortem, consisting of three-repeat (3R) or four-repeat (4R) tau isoforms, or a combination (3R + 4R). Here, we studied grey matter tau burden, its relation to neuronal degeneration, and regional patterns of pathology in different isoform groups of FTLD-MAPT. We included 38 FTLD-MAPT autopsy cases with 10 different MAPT pathogenic variants, grouped based on predominant tau isoform(s). In up to eleven regions (ten cortical and one striatal), we quantified grey matter tau burden using digital histopathological analysis and assigned semi-quantitative ratings for neuronal degeneration (i.e. 0-4) and separate burden of glial and neuronal tau inclusions (i.e. 0-3). We used mixed modelling to compare pathology measures (1) across the entire cohort and (2) within isoform groups. In the total cohort, tau burden and neuronal degeneration were positively associated and most severe in the anterior temporal, anterior cingulate and transentorhinal cortices. Isoform groups showed distinctive features of tau burden and neuronal degeneration. Across all regions, the 3R isoform group had lower tau burden compared to the 4R group (p = 0.008), while at the same time showing more severe neuronal degeneration than the 4R group (p = 0.002). The 3R + 4R group had an intermediate profile with relatively high tau burden along with relatively severe neuronal degeneration. Neuronal tau inclusions were most frequent in the 4R group (p < 0.001 vs. 3R), while cortical glial tau inclusions were most frequent in the 3R + 4R and 4R groups (p ≤ 0.009 vs. 3R). Regionally, neuronal degeneration was consistently most severe in the anterior temporal cortex within each isoform group. In contrast, the regions with the highest tau burden differed in isoform groups (3R: striatum; 3R + 4R: striatum, inferior parietal lobule, middle frontal cortex, anterior cingulate cortex; 4R: transentorhinal cortex, anterior temporal cortex, fusiform gyrus). We conclude that FTLD-MAPT isoform groups show distinctive features of overall neuronal degeneration and regional tau burden, but all share pronounced anterior temporal neuronal degeneration. These data suggest that distinct isoform-related mechanisms of genetic tauopathies, with slightly divergent tau distribution, may share similar regional vulnerability to neurodegeneration within the frontotemporal paralimbic networks.
Identifiants
pubmed: 36066634
doi: 10.1007/s00401-022-02487-4
pii: 10.1007/s00401-022-02487-4
pmc: PMC9995405
doi:
Substances chimiques
tau Proteins
0
Protein Isoforms
0
MAPT protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1065-1084Subventions
Organisme : NIA NIH HHS
ID : P01 AG066597
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072979
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS109260
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG052943
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Références
J Neuropathol Exp Neurol. 2014 Jan;73(1):81-97
pubmed: 24335532
Acta Neuropathol. 2018 Nov;136(5):699-708
pubmed: 30276465
Brain. 2019 Jul 1;142(7):2068-2081
pubmed: 31081015
J Neurochem. 2016 Aug;138 Suppl 1:54-70
pubmed: 27306735
J Neural Transm (Vienna). 2012 Dec;119(12):1551-60
pubmed: 22678700
Ann Neurol. 1998 Jun;43(6):815-25
pubmed: 9629852
Brain. 2012 Mar;135(Pt 3):794-806
pubmed: 22366795
Acta Neuropathol. 2003 Oct;106(4):323-36
pubmed: 12883828
Neurocase. 2012;18(6):478-88
pubmed: 22181323
Nature. 2018 Sep;561(7721):137-140
pubmed: 30158706
Ann Neurol. 2003 Jan;53(1):133-7
pubmed: 12509859
Alzheimers Dement. 2014 Jul;10(4):477-484.e1
pubmed: 23978324
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
Brain. 2018 Feb 1;141(2):521-534
pubmed: 29253099
Pathogens. 2021 Mar 05;10(3):
pubmed: 33807776
Acta Neuropathol. 2016 Jan;131(1):87-102
pubmed: 26659578
Brain. 2018 Jan 1;141(1):288-301
pubmed: 29228211
Ann Clin Transl Neurol. 2021 Jan;8(1):95-110
pubmed: 33247623
Front Aging Neurosci. 2020 Apr 09;12:96
pubmed: 32327993
Brain. 2016 Sep;139(Pt 9):2372-9
pubmed: 27357347
Lab Invest. 2019 Jul;99(7):912-928
pubmed: 30742061
Eur J Neurol. 2015 May;22(5):745-52
pubmed: 25683866
J Biol Chem. 2012 Jun 8;287(24):20711-9
pubmed: 22539343
J Neurol. 2019 Aug;266(8):2075-2086
pubmed: 31119452
Alzheimers Res Ther. 2021 Feb 10;13(1):42
pubmed: 33568215
Acta Neuropathol. 2019 Nov;138(5):705-727
pubmed: 31203391
J Neuropathol Exp Neurol. 2007 Jan;66(1):17-25
pubmed: 17204933
Histopathology. 2003 Jun;42(6):521-9
pubmed: 12786887
Acta Neuropathol. 2009 Apr;117(4):429-44
pubmed: 19194716
Neurology. 2021 Aug 31;97(9):e941-e952
pubmed: 34158384
Am J Pathol. 2001 Sep;159(3):937-43
pubmed: 11549586
Mol Neurodegener. 2021 Aug 23;16(1):57
pubmed: 34425874
Neurology. 2009 Mar 3;72(9):813-20
pubmed: 19255408
Arch Neurol. 2005 Sep;62(9):1402-8
pubmed: 16157747
Acta Neuropathol. 2007 Apr;113(4):471-9
pubmed: 17072625
Ann Neurol. 2016 Feb;79(2):272-87
pubmed: 26583316
Neurobiol Aging. 2018 Feb;62:191-196
pubmed: 29172163
Brain. 2011 Sep;134(Pt 9):2565-81
pubmed: 21908872
Neurology. 2021 Sep 7;97(10):e1017-e1030
pubmed: 34210823
Ann Neurol. 2003 Nov;54(5):573-81
pubmed: 14595646
Brain. 2005 Nov;128(Pt 11):2645-53
pubmed: 16014652
Neuropathol Appl Neurobiol. 2015 Feb;41(1):24-46
pubmed: 25556536
Acta Neuropathol. 2020 Jan;139(1):63-77
pubmed: 31616982
Nat Rev Neurosci. 2016 Jan;17(1):5-21
pubmed: 26631930
Neuropathol Appl Neurobiol. 2015 Feb;41(1):3-23
pubmed: 25495175
Sci Transl Med. 2022 Jan 05;14(626):eabg0253
pubmed: 34985969
Nature. 2021 Oct;598(7880):359-363
pubmed: 34588692
Neuropathol Appl Neurobiol. 2017 Apr;43(3):200-214
pubmed: 27859539
Acta Neuropathol Commun. 2020 Feb 22;8(1):22
pubmed: 32087764
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S29-33
pubmed: 26382841
Am J Pathol. 2013 Aug;183(2):344-51
pubmed: 23885714
Annu Rev Neurosci. 2017 Jul 25;40:189-210
pubmed: 28772101
Acta Neuropathol Commun. 2021 Feb 23;9(1):30
pubmed: 33622418
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7737-41
pubmed: 9636220
Front Neurosci. 2019 Jul 03;13:682
pubmed: 31333403
Acta Neuropathol Commun. 2019 Oct 22;7(1):159
pubmed: 31640778
Neurology. 2018 Mar 13;90(11):e947-e954
pubmed: 29440563
Neurobiol Aging. 2017 May;53:195.e11-195.e17
pubmed: 28268100
Alzheimers Dement (N Y). 2019 Jul 30;5:338-346
pubmed: 31388560
Brain. 2022 Jun 3;145(5):1763-1772
pubmed: 34664612
J Neuropathol Exp Neurol. 1999 Apr;58(4):335-45
pubmed: 10218629
Prion. 2020 Dec;14(1):249-256
pubmed: 33171070
Ann N Y Acad Sci. 2000;920:52-62
pubmed: 11193177
J Alzheimers Dis. 2020;75(2):595-606
pubmed: 32310161
Acta Neuropathol. 2006 Apr;111(4):329-40
pubmed: 16552612
Nature. 1998 Jun 18;393(6686):702-5
pubmed: 9641683
Acta Neuropathol. 2011 Jul;122(1):111-3
pubmed: 21644037
Curr Opin Struct Biol. 2020 Oct;64:17-25
pubmed: 32603876
Mov Disord. 2019 Nov;34(11):1655-1662
pubmed: 31433871
Eur J Neurol. 2008 Apr;15(4):377-85
pubmed: 18284428
Cell. 2020 Dec 10;183(6):1699-1713.e13
pubmed: 33188775
Nature. 2020 Apr;580(7802):283-287
pubmed: 32050258
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
J Alzheimers Dis. 2010;22(4):1313-29
pubmed: 20930284
Alzheimers Res Ther. 2019 Jan 31;11(1):13
pubmed: 30704514
Ann Neurol. 2002 Mar;51(3):373-6
pubmed: 11891833
Acta Neuropathol. 1999 Jul;98(1):62-77
pubmed: 10412802
Nature. 2019 Apr;568(7752):420-423
pubmed: 30894745
Dement Geriatr Cogn Disord. 2017;44(3-4):213-221
pubmed: 28934750
J Histochem Cytochem. 2016 Jan;64(1):54-66
pubmed: 26538548
Lancet Neurol. 2013 Jun;12(6):609-22
pubmed: 23684085
Neurology. 2020 Dec 15;95(24):e3190-e3202
pubmed: 32989107
Ann Neurol. 2019 May;85(5):630-643
pubmed: 30851133
J Mol Neurosci. 2011 Nov;45(3):384-9
pubmed: 21720721
Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12792
pubmed: 35064600
Acta Neuropathol. 2020 Aug;140(2):99-119
pubmed: 32383020